Literature DB >> 16810637

Quantification of tizanidine in human plasma by liquid chromatography coupled to tandem mass spectrometry.

Ramakrishna V S Nirogi1, Vishwottam N Kandikere, Manoj Shukla, Koteshwara Mudigonda, Santosh Maurya.   

Abstract

A simple, sensitive and rapid high-performance liquid chromatography/positive ion electrospray tandem mass spectrometry (MS/MS) method was developed and validated for the assay of tizanidine in human plasma. Following liquid-liquid extraction, the analytes were separated using an isocratic mobile phase on a reversed-phase column and analyzed by MS/MS in the selected reaction monitoring mode. The assay exhibited a linear dynamic range of 50-5000 pg/mL for tizanidine in human plasma. The lower limit of quantification was 50 pg/mL with a relative standard deviation of less than 13%. Acceptable precision and accuracy were obtained for concentrations over the standard curve range. A run time of 2.5 min for each sample made it possible to analyze more than 300 human plasma samples per day. The validated method has been successfully used to analyze human plasma samples for application in pharmacokinetic, bioavailability or bioequivalence studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16810637     DOI: 10.1002/rcm.2592

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  2 in total

1.  Tizanidine-induced hypotension in patients with liver cirrhosis.

Authors:  Kenji Momo; Masato Homma; Makoto Abei; Ichinosuke Hyodo; Yukinao Kohda
Journal:  Eur J Clin Pharmacol       Date:  2008-06       Impact factor: 2.953

2.  Pharmacokinetic characterization of tizanidine nasal spray, a novel intranasal delivery method for the treatment of skeletal muscle spasm.

Authors:  Daniela Cristina Vitale; Cateno Piazza; Tiziana Sinagra; Vincenzo Urso; Francesco Cardì; Filippo Drago; Salvatore Salomone
Journal:  Clin Drug Investig       Date:  2013-12       Impact factor: 2.859

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.